Insider · CIK 0001760511
Jeff Evanson
Files at OTLK (Outlook Therapeutics, Inc.). First filing Mar 11, 2024, latest Mar 11, 2024.
In brief
Jeff Evanson files SEC Form 4 as officer at OTLK (Outlook Therapeutics, Inc.). Since Mar 11, 2024, Jeff Evanson has reported 1 open-market buy worth $26k and 0 open-market sells worth $0, the latest filed on Mar 11, 2024.
A track record needs three past buys with six months of prices behind them; Jeff Evanson has 0, so none is measured yet.
The newest scored trade: bought $26k of OTLK on Mar 7, 2024, filed Mar 11, 2024, scored 31 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OTLK: Outlook Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | OTLKbuy Outlook Therapeutics, Inc. | $26k 62,484 shares | +8% | +101% from low-78% from high |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 20, 2024 | OTLK Outlook Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Mar 22, 2024 |
| Mar 7, 2024 | OTLK Outlook Therapeutics, Inc. | POpen-market purchase Common Stock | +62,484 | $0.42 | $26k | 808,459 | Mar 11, 2024 |
Questions about Jeff Evanson
Answered from the filings on this page, as of the latest one.
Is Jeff Evanson buying or selling?
Not in the last 12 months. Jeff Evanson's latest open-market trade on SEC Form 4 was bought $26k of OTLK on Mar 7, 2024.
How did Jeff Evanson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jeff Evanson has 0.
Where does Jeff Evanson file Form 4?
Jeff Evanson has filed Form 4 at OTLK (Outlook Therapeutics, Inc.) as CHIEF COMMERCIAL OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.